• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[255例膀胱肿瘤患者的治疗]

[Treatment of 255 patients with bladder tumors].

作者信息

Aso Y, Ushiyama T, Tajima A, Suzuki K, Ohtawara Y, Ohta N, Ohmi Y, Hata M, Masuda H, Kanbayashi T

出版信息

Nihon Hinyokika Gakkai Zasshi. 1989 Jan;80(1):74-81. doi: 10.5980/jpnjurol1989.80.74.

DOI:10.5980/jpnjurol1989.80.74
PMID:2724748
Abstract

During about 10 years from November, 1977 to March, 1987, two hundreds and fifty-five patients with bladder tumors were treated at the Department of Urology, Hamamatsu University School of Medicine and the affiliated hospitals. There were 198 males and 57 females with the highest age incidence in the seventies. Histologically, 242, 11 and 2 tumors were of transitional cell, squamous cell and adenocarcinoma, respectively. Of the 242 transitional cell carcinomas, 7 were Tis; 43 Ta, 111 T1, 33 T2, 19 T3, 5 T4, 14 M+ (with metastatic lesion), and 10 TX. As to grading, 6 was G0; 66 G1, 100 G2, 64 G3, and 6 GX. Staging was correlated with grading. The 5-year survival rates (Kaplan-Meier's method) were 64% in patients with transitional cell carcinoma; 58% in those with squamous cell carcinoma. In patients with transitional cell carcinoma, the 5-year survival rates were 100% for G0, 73% for G1, 73% for G2 and 40% for G3. As to staging, the 5-year survival rates were 67%, 81%, 81%, 35%, 41%, 40% and 12% in patients with stage of Tis, Ta, T1, T2, T3, T4 and M+, respectively. As to the initial treatment, the 5-year survival rates after TUR (137 cases), partial cystectomy (4 cases) and total cystectomy (56 cases) were 81%, 36% and 61%, respectively. The rate of intravesical recurrence after TUR was evaluated with the cumulative non-recurrence rate calculated by Kaplan-Meier's method.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在1977年11月至1987年3月约10年的时间里,静冈大学医学院泌尿外科及其附属医院共治疗了255例膀胱肿瘤患者。其中男性198例,女性57例,年龄发病率最高的年龄段为70岁。组织学上,移行细胞癌242例,鳞状细胞癌11例,腺癌2例。在242例移行细胞癌中,Tis期7例;Ta期43例,T1期111例,T2期33例,T3期19例,T4期5例,M+(有转移灶)14例,TX期10例。分级方面,G0期6例;G1期66例,G2期100例,G3期64例,GX期6例。分期与分级相关。移行细胞癌患者的5年生存率(Kaplan-Meier法)为64%;鳞状细胞癌患者为58%。移行细胞癌患者中,G0期5年生存率为100%,G1期为73%,G2期为73%,G3期为40%。分期方面,Tis、Ta、T1、T2、T3、T4和M+期患者的5年生存率分别为67%、81%、81%、35%、41%、40%和12%。初始治疗方面,经尿道膀胱肿瘤切除术(137例)、膀胱部分切除术(4例)和膀胱全切除术(56例)后的5年生存率分别为81%、36%和61%。经尿道膀胱肿瘤切除术后膀胱内复发率采用Kaplan-Meier法计算的累积无复发率进行评估。(摘要截断于250字)

相似文献

1
[Treatment of 255 patients with bladder tumors].[255例膀胱肿瘤患者的治疗]
Nihon Hinyokika Gakkai Zasshi. 1989 Jan;80(1):74-81. doi: 10.5980/jpnjurol1989.80.74.
2
[Treatment of 46 cases of renal pelvic and ureteral tumors].[46例肾盂及输尿管肿瘤的治疗]
Nihon Hinyokika Gakkai Zasshi. 1989 Jan;80(1):69-73. doi: 10.5980/jpnjurol1989.80.69.
3
[Treatment of 300 patients with bladder cancer].[300例膀胱癌患者的治疗]
Hinyokika Kiyo. 1991 Oct;37(10):1235-41.
4
Conservative treatment of bladder carcinoma by partial cystectomy and interstitial iridium 192.通过膀胱部分切除术和组织间铱192对膀胱癌进行保守治疗。
Int J Radiat Oncol Biol Phys. 1988 Dec;15(6):1323-30. doi: 10.1016/0360-3016(88)90227-1.
5
[Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].[根治性膀胱切除术治疗浸润性膀胱癌的结果,特别提及根据尿流改道类型的预后因素和生活质量]
Ann Acad Med Stetin. 2000;46:217-29.
6
[Prognosis of bladder tumor patients treated by TUR].经尿道膀胱肿瘤切除术治疗的膀胱肿瘤患者的预后
Hinyokika Kiyo. 1989 Sep;35(9):1497-501.
7
[Survival rate of bladder tumors--an analysis of 2304 patients with bladder tumors in the Tokai Urological Cancer Registry].[膀胱肿瘤的生存率——对东海泌尿生殖系统癌症登记处2304例膀胱肿瘤患者的分析]
Nihon Hinyokika Gakkai Zasshi. 1990 Jan;81(1):96-102. doi: 10.5980/jpnjurol1989.81.96.
8
[A clinical investigation on renal pelvic and ureteral tumors].[肾盂及输尿管肿瘤的临床研究]
Hinyokika Kiyo. 1991 Aug;37(8):851-6.
9
Clinical study of G3 superficial bladder cancer without concomitant CIS treated with conservative therapy.
Jpn J Clin Oncol. 2002 Nov;32(11):461-5. doi: 10.1093/jjco/hyf103.
10
High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.高危浅表性膀胱癌:膀胱内灌注治疗膀胱T1 G3移行细胞癌
Semin Urol Oncol. 1997 Aug;15(3):147-53.